Structural and functional analysis of β2 microglobulin abnormalities in human lung and breast cancer

International Journal of Cancer

Volumn 67, Issue 6, 1996, Pages 756-763

  Chen, Hailei L ^a   Gabrilovich, Dmitry ^a   Virmani, Arvind ^a   Ratnani, Ikki ^a   Girgis, Khaled R ^a   Nadaf Rahrov, Sorena ^a   Fernandez VIÑA, Marcelo ^a   Carbone, David P ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

BETA 2-MICROGLOBULIN; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; EXONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC SURVEILLANCE; LUNG NEOPLASMS; MUTATION; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029958611     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960917)67:6<756::AID-IJC2>3.0.CO;2-Q     Document Type: Article

References (31)

1. ABDEL MOTAL, U.M., ZHOU, M.X., SIDDIQI, A.R. and JONDAL, M., Regulation of MHC class I membrane expression by beta 2-microglobulin. Scand. J. Immunol., 38, 395-400 (1993).
2. + T cells. J. clin. Invest., 94, 797-807 (1994).
3. BICKNELL, D.C., ROWAN, A. and BODMER, W.F., Beta-2 microglobulin gene mutations: A study of established colorectal cell lines and fresh tumors. Proc. nat. Acad. Sci. (Wesh.), 91, 4751-4755 (1994).
4. BODMER, H., OGG, G., GOTCH, F. and MCMICHAEL, A., Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature (Lond.), 342, 443-446 (1989).
5. DEGEN, E., COHEN-DOYLE, M.F. and WILLIAMS, D.B., Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both β2-microglobulin and peptide. J. exp. Med., 175, 1653-1661 (1992).
6. DOYLE, A., MARTIN, W.J., FUNA, K., GAZDAR, A., CARNEY, D., MARTIN, S.E., LINNOILA, I., CUTITTA, F., MULSHINE, J., BUNN, P. and MINNA, J.D., Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J. exp. Med., 161, 1135-1151 (1985).
7. D'URSO, C.M., WANG, Z.G., CAO, Y., TATAKE, R., ZEFF, R.A. and FERRONE, S., Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J. clin. Invest., 87, 284-292 (1991).
8. GATTONI-CELLI, S., KIRSCH, K., TIMPANE, R. and ISSELBACHER, K.J., Beta 2-microglobulin gene is mutated in a human colon cancer cell line (HCT) deficient in the expression of HLA class I antigens on the cell surface. Cancer Res., 52, 1201-1204 (1992).
9. GÜSSOW, D., REIN, R., GINJAAR, I., HOCHSTENBACH, F., SEEMANN, G., KOTTMAN, A. and PLOEGH, H.L., The human β2-microglobulin gene: Primary structure and definition of the transcription unit. J. Immunol., 139, 3132-3138 (1987).
10. HANSEN, T.H., MYERS, N.B. and LEE, D.R., Studies of two antigenic forms of Ld with disparate beta 2-microglobulin associations suggest that beta 2m facilitate the folding of the alpha 1 and alpha 2 domains during de novo synthesis. J. Immunol., 140, 3522-3527 (1988).
11. HUI, K., GROSVELD, F. and FESTENSTEIN, H., Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation. Nature (Lond.), 311, 750-752 (1984).
12. JEFFERIES, W.A., KOLAITIS, G. and GABATHULER, R., IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides. J. Immunol., 151, 2974-2985 (1993).
13. KAKLAMAMS, L., LEEK, R., KOUKOURAKIS, M., GATTER, K.C. and HARRIS, A.L., Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic breast cancer. Cancer Res., 55, 5191-5194 (1995).
14. KOZLOWSKI, S., TAKESHITA, T., BOEHCKE, W.-H., TAKAHASHI, H., BOYD, L.F., GERMAIN, R.N., BERZOFSKY, J.A. and MARGULIES, D.H., Excess β2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules. Nature (Lond.), 349, 74-77 (1991).
15. LAMPSON, L.A., FISHER, C.A. and WHELAN, J.P., Striking paucity of HLA-A.B.C. and β2-microglobulin antigens on human neuroblastoma cell lines. J. Immunol., 130, 2471-2478 (1983).
16. MOMBURG, F. and KOCH, S., Selective loss of beta 2-microglobulin mRNA in human colon carcinoma. J. exp. Med., 169, 309-314 (1989).
17. MOMBURG, F., ZIEGLER, A., HARPPRECHT, J., MÖLLER, P., MOLDENHAUER, G. and HÄMMERLING, G.J., Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. J. Immunol., 142, 352-358 (1989).
18. PLOEGH, H.L., ORR, H.T. and STROMINGER, J.L., Major histocompatibility antigens: the human(HLA-A,-B,-C) and murine(H-2k,H-2D)class I molecules. Cell, 24, 287-299 (1981).
19. REIN, R.S., SEEMANN, G.H., NEEFJES, J.J., HOCHSTENBACH, F.M., STAM, N.J. and PLOEGH, H.L., Association with beta 2-microglobulin controls the expression of transfected human class I genes. J. Immunol., 138, 1178-1183 (1987).
20. RESTIFO, N.P., ESQUIVEL, F., KAWAKAMI, Y., YEWDELL, J.W., MULE, J.J., ROSENBERG, S.A. and BENNINK, J.R., Identification of human cancers deficient in antigen processing. J. exp. Med., 177, 265-272 (1993).
21. + cells against the wild type tumor: correlation with antigen presentation capacity. J. exp. Med., 175, 1423-1431 (1992).
22. ROSA, F., BERISSI, H., WEISSENBACH, J., MAROTEAUX, L., FELLOUS, M. and REVEL, M., The beta-2-mocroglobulin mRNA in human Daudi cells has a mutated initiation codon out is still inducible by Interferon. EMBO J., 2, 239-243 (1983).
23. SEONG, R.H., CLAYBERGER, C.A., KRENSKY, A.M. and PARNES, J.R., Rescue of Daudi cell HLA expression by transfection of the mouse beta 2-microglobulin gene. J. exp. Med., 167, 288-299 (1988).
24. TANAKA, K., ISSELBACHER, K.J., KHOURY, G. and JAY, G., Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science, 228, 26-30 (1985).
25. TOWNSEND, A. and BODMER, H., Antigen recognition by class I-restricted T lymphocytes. Ann. Rev. Immunol., 7, 601-624 (1989).
26. TROWSDALE, J., TRAVERS, P., BODMER, W.F. and PATILLO, R.A., Expression of HLA-A,-B, and -C and β2-microglobulin antigens in human choriocarcinoma cell lines. J. exp. Med., 152 (Suppl.), 11s. (1980).
27. VITIELLO, A., POTTER, T. and SHERMAN, L.A., The role of β2-microglobulin in peptide binding by class I molecules. Science, 250, 1423-1426 (1990).
28. WANG, Z., CAO, Y., ALBINO, A.P., ZEFF, R.A., HOUGHTON, A. and FERRONE, S., Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobuliin messenger RNA. J. clin. Invest., 91, 684-92 (1993).
29. WIEDENFELD, E.A., FERNANDEZ-VIÑA, M., BERZOFSKY, J.A. and CARBONE, D.P., Evidence for selection against human lung cancers bearing p53 missense mutations which occur within the HLA A*0201 peptide consensus motif. Cancer Res., 54, 1175-1177 (1994).
30. WILLIAMS, D., BARBER, B., FLAVELL, R. and ALLEN, H., Role of β2-microglobulin in the intracellular transport and surface expression of murine class I histocompatibility molecules. J. Immunol., 142, 2796-2806 (1989).
31. + cytolytic T cells. Nature (Lond.), 344, 742-746 (1990).